Severity: Warning
Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 197
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 197
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 271
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3165
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 597
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 511
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 317
Function: require_once
98%
921
2 minutes
20
Cancer remains a critical global health challenge, demanding innovative biomarkers and therapeutic targets for improved diagnosis and treatment. Extracellular vesicles (EVs), which are cell-secreted entities facilitating intercellular communication, have emerged as promising non-invasive biomarkers in oncology. This review focuses on the role of EVs in cancer diagnosis and therapy, covering their biogenesis, isolation, characterization, and functional implications. It emphasizes engineered EV modifications for biomedical tumor therapy, highlighting EV sources for vaccines, tumor immunotherapy activation, tumor microenvironment modulation, and enhanced nanodynamic therapy. Finally, it discusses the opportunities and challenges in translating EVs to clinical practice. By integrating recent findings, this review underscores the significance of EVs in revolutionizing cancer management through advanced diagnostics and effective therapies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/d5tb01154j | DOI Listing |